TrialClinical pharmacokinetics2016

Dose-Dependent Bioavailability and CYP3A Inhibition Contribute to Non-Linear Pharmacokinetics of Voriconazole.

Nicolas Hohmann et al.PubMed ↗Publisher ↗

No numbers read from the abstract.